Literature DB >> 20337922

Quality of life in patients with various liver diseases: patients with HCV show greater mental impairment, while patients with PBC have greater physical impairment.

H L Tillmann1, M Wiese, Y Braun, J Wiegand, S Tenckhoff, J Mössner, M P Manns, K Weissenborn.   

Abstract

Little is known comparing and contrasting quality of life (QoL) in patients with hepatitis C, compared to patients with other liver diseases. We performed two independent prospective cross-sectional studies including 511 and 284 patients with different forms of liver diseases. SF-36 was used in both studies. Fatigue Impact Score, WHO-BREF and Hospital Anxiety and Depression Scale (HADS) were used in either study only. In both studies, HCV-positive patients scored worse in the mental aspects of health-related QoL compared to other liver diseases, except for HBV in one study. Surprisingly, in both studies, quality of life was also significantly impaired in patients with viral clearance after interferon therapy but not after spontaneous clearance. Furthermore, patients with primary biliary cirrhosis showed significantly better mental health but significantly worse physical well-being. Liver diseases differ in their form of impaired QoL. In HCV, this impairment might not always return to normal after treatment-induced viral clearance. This may suggest that HCV either may not be involved in QoL impairment or may induce a process which persists after viral clearance in some patients.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 20337922     DOI: 10.1111/j.1365-2893.2010.01292.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  15 in total

1.  Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency.

Authors:  David A Sheridan; S H Bridge; M M E Crossey; D J Felmlee; H C Thomas; R D G Neely; S D Taylor-Robinson; M F Bassendine
Journal:  Metab Brain Dis       Date:  2014-03-12       Impact factor: 3.584

2.  Outcomes of Palliative Care Consultations for Hospitalized Patients With Liver Disease.

Authors:  Nneka N Ufere; David L O'Riordan; Kara E Bischoff; Angela K Marks; Nwamaka Eneanya; Raymond T Chung; Vicki Jackson; Steven Z Pantilat; Areej El-Jawahri
Journal:  J Pain Symptom Manage       Date:  2019-07-19       Impact factor: 3.612

3.  Cerebral glucose utilisation in hepatitis C virus infection-associated encephalopathy.

Authors:  Meike Heeren; Karin Weissenborn; Dimitrios Arvanitis; Martin Bokemeyer; Annemarie Goldbecker; Argyro Tountopoulou; Thomas Peschel; Julian Grosskreutz; Hartmut Hecker; Ralph Buchert; Georg Berding
Journal:  J Cereb Blood Flow Metab       Date:  2011-06-01       Impact factor: 6.200

4.  Recent viral infection in US blood donors and health-related quality of life (HRQOL).

Authors:  Farnaz Vahidnia; Susan L Stramer; Debra Kessler; Beth Shaz; German Leparc; David E Krysztof; Simone A Glynn; Brian Custer
Journal:  Qual Life Res       Date:  2016-08-17       Impact factor: 4.147

5.  Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study.

Authors:  Souvik Sarkar; Zhen Jiang; Donna M Evon; Abdus S Wahed; Jay H Hoofnagle
Journal:  J Hepatol       Date:  2012-07-01       Impact factor: 25.083

6.  Impairment of health-related quality of life in patients with chronic hepatitis C is associated with insulin resistance.

Authors:  Takuya Kuwashiro; Toshihiko Mizuta; Yasunori Kawaguchi; Shinji Iwane; Hirokazu Takahashi; Noriko Oza; Satoshi Oeda; Hiroshi Isoda; Yuichiro Eguchi; Iwata Ozaki; Keizo Anzai; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2013-03-16       Impact factor: 7.527

Review 7.  Depression, fatigue and neurocognitive deficits in chronic hepatitis C.

Authors:  Sern Wei Yeoh; Alex C N Holmes; Michael M Saling; Ian P Everall; Amanda J Nicoll
Journal:  Hepatol Int       Date:  2018-06-21       Impact factor: 6.047

8.  Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN).

Authors:  Donna M Evon; Abdus S Wahed; Geoffrey Johnson; Mandana Khalili; Mauricio Lisker-Melman; Robert J Fontana; Souvik Sarkar; Bryce B Reeve; Jay H Hoofnagle
Journal:  Dig Dis Sci       Date:  2016-01-30       Impact factor: 3.199

9.  Validation of the chronic liver disease questionnaire in Serbian patients.

Authors:  Dusan Dj Popovic; Nada V Kovacevic; Darija B Kisic Tepavcevic; Goran Z Trajkovic; Tamara M Alempijevic; Milan M Spuran; Miodrag N Krstic; Rada S Jesic; Zobair M Younossi; Tatjana D Pekmezovic
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

10.  TRAF1-C5 affects quality of life in patients with primary biliary cirrhosis.

Authors:  Joanna Raszeja-Wyszomirska; Ewa Wunsch; Agnieszka Kempinska-Podhorodecka; Daniel S Smyk; Dimitrios P Bogdanos; Malgorzata Milkiewicz; Piotr Milkiewicz
Journal:  Clin Dev Immunol       Date:  2013-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.